Kyphoplasty and Percutaneous Discectomy Procedure Market Size and Forecast — 2026-2033
Kyphoplasty and Percutaneous Discectomy Procedure Market is estimated to be valued at USD 2,600.1 Mn in 2026 and is expected to reach USD 3,883.8 Mn in 2033, exhibiting a compound annual growth rate (CAGR) of 5.9% from 2026 to 2033. Utilizing kyphoplasty, a particular cement is injected into the vertebrae, and an additional step is taken to make room for the procedure with a balloon-like device (balloon vertebroplasty). Kyphoplasty can increase the height of a damaged vertebra and may also be pain-relieving.
Figure 1.Global Kyphoplasty and Percutaneous Discectomy Procedure Market Share (%), by Procedure, 2026

Global Kyphoplasty and Percutaneous Discectomy Procedure Market- Drivers
Increasing prevalence of Vertebral Compression Fractures (VCF), osteoporosis, and other spinal disorders is expected to drive market growth over the forecast period. For instance, according to the American Association of Neurological Surgeons, VCFs are the most common fracture in patients with osteoporosis, that affect about 750,000 people annually in the U.S. VCFs affect an estimated 25% of all postmenopausal women in the U.S.
The increasing demand for minimally invasive surgical procedures in orthopedics and thereby improvements in reimbursement policies is expected to further drive the market growth. For instance, in September 2020, the SpineJack implantable fracture reduction system of Stryker, a multinational medical technologies company, received the U.S. Centers for Medicare & Medicaid Services (CMS) New Technology Add-on Payment (NTAP) as part of the 2021 inpatient prospective payment system. The SpineJack System is an implanted fracture reduction system, intended to reduce vertebral compression fractures. After the SpineJack implant is inserted, it is expanded, and Vertaplex HV bone cement is injected at a low pressure to stabilize the restored vertebral body.
- Current Industry Events of 2026
- Market Size Estimation
- Regional Breakdown
- Competitive Landscape
- Customer Intelligence
- Segmental Analysis
- Pricing Analysis
- Key Market Drivers, Challenges & Future Trends
- Customized Insights Section
Kyphoplasty and Percutaneous Discsectomy Procedure Market Report Coverage
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 2,600.1 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.9% | 2033 Value Projection: | USD 3,883.8 Mn |
| Geographies covered: |
| ||
| Segments covered: |
| ||
| Companies covered: | Stryker, Medtronic Inc., BPB Medica – Biopsybell, Smith & Nephew, MicroPort Scientific Corporation, Johnson & Johnson, Halma plc, Becton, Dickinson and Company , Merit Medical Systems, Joimax GmbH, G21 S.r.l., Joline GmbH & Co. KG, Seawon MediTech | ||
| Growth Drivers: |
| ||
| Restraints & Challenges: |
| ||
Figure 2. Global Kyphoplasty and Percutaneous Discectomy Procedure Market Share (%), by Application, 2026

For instance, as per a study published in May 2020, in Asian Spine Journal, spine surgical procedures decreased by approximately 50% in the first month of covid wave in France as compared to the same period in 2019.
Global Kyphoplasty and Percutaneous Discectomy Procedure Market: Key Developments
In September 2021, Spinal Elements, a spine technology company, announced the full commercial launch of the Luna XD multiexpandable lumbar interbody fusion device and Orbit articulating discectomy systems. Luna XD and Orbit have been integrated into Spinal Elements as the newest technologies in its Minimally Invasive Spine (MIS) Ultra platform of products and procedural solutions.
In January, Merit Medical Systems, a manufacturer and marketer of proprietary disposable medical devices, announced the official market launch of Arcadia Steerable and Straight Balloons for vertebral augmentation. Arcadia balloons are designed to help physicians achieve controlled, precise cavity creation during unipedicular or bipedicular vertebral augmentation and kyphoplasty procedures
Global Kyphoplasty and Percutaneous Discectomy Procedure Market: Restraint
The high cost of minimally invasive procedures is expected to hamper the market growth. The price of spinal surgeries is very high, which can hamper the market growth. For instance, according to New Choice Health, Inc., a free, consumer-focused healthcare marketplace, the national average cost of vertebral augmentation surgery such as vertebroplasty and kyphoplasty is US$ 36,880 in the U.S. According to the same source, the average price range for kyphoplasty is US$ 11,300 to US$ 31,000 in the U.S.
Global Kyphoplasty and Percutaneous Discectomy Procedure Market- Key Players
Major players operating in the global kyphoplasty and percutaneous discectomy procedure market include Stryker, Medtronic Inc., BPB Medica – Biopsybell, Smith & Nephew, MicroPort Scientific Corporation, Johnson & Johnson, Halma plc, Becton, Dickinson and Company, Merit Medical Systems, Joimax GmbH, G21 S.r.l., Joline GmbH & Co. KG, and Seawon MediTech
Sources
Primary Research Interviews
- Kyphoplasty and percutaneous discectomy device makers (e.g., Medtronic Kyphon, Stryker, Johnson & Johnson/DePuy Synthes, Merit Medical)
- Interventional radiologists, neurosurgeons and orthopedic spine surgeons
- Hospital and ASC procurement heads
Databases
- U.S. FDA 510(k)/PMA spinal device database
- CMS vertebral augmentation claims
- EUDAMED registrations
Magazines
- Orthopedics This Week
- Endovascular Today
Journals
- The Spine Journal (NASS)
- Journal of Vascular and Interventional Radiology (SIR)
Newspapers
- Reuters Health
- Financial Times – MedTech
Associations
- NASS
- SIR
- AANS/CNS Spine
Public Domain Sources
- U.S. FDA spine device guidance
- NICE vertebroplasty guidance
- ResearchGate publications on kyphoplasty
Proprietary Elements
- CMI Data Analytics Tool, Proprietary CMI Existing Repository of information for last 10 years.
Get access to 250+ pages report
Every segment, forecast, competitor profile and data table behind the analysis above — available for instant download.
- ESOMAR Member
- ISO 9001:2015 Certified
- D-U-N-S Registered
- GDPR & CCPA Compliant
Missing comfort of reading report in your local language? Find your preferred language:
Transform your Strategy with Exclusive Trending Reports
Frequently Asked Questions
The Kyphoplasty and Percutaneous Discectomy Procedure Market is estimated to be valued at USD 2,600.1 Mn in 2026, and is expected to reach USD 3,883.8 Mn by 2033.
The CAGR of the Kyphoplasty and Percutaneous Discectomy Procedure Market is projected to be 5.9% from 2026 to 2033.
Factors such as the increasing prevalence of Vertebral Compression Fractures (VCF), osteoporosis, and other spinal disorders and improving reimbursement policies are expected to drive the market.
Spinal Fractures is the leading application segment in the market.
The major factors hampering the growth of the global kyphoplasty and percutaneous discectomy procedure market include the high cost of spinal surgeries and the presence of alternative surgeries.
Major players operating in the market include Stryker, Medtronic Inc., BPB Medica – Biopsybell, Smith & Nephew, MicroPort Scientific Corporation, Johnson & Johnson, Halma plc, Becton, Dickinson and Company, Merit Medical Systems, Joimax GmbH, G21 S.r.l., Joline GmbH & Co. KG, and Seawon MediTech
